Andrographis paniculata

Botanicalexperimental

Andrographis paniculata, commonly known as creat or green chiretta, is an annual herbaceous plant in the family Acanthaceae, native to India and Sri Lanka. — Wikipedia

Clinical trial activity

21 trials · 36 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
10
Phase 3
6
Phase 4
4

Earliest trial started Apr 1, 2006 (NCT00655733)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • andrographis
  • andrographis
  • andrographis paniculata extract
  • andrographolide
  • andrographolide
  • andrographolide sulfonate
  • hmpl004
  • hmpl-004

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06520527N/AJul 21, 2024Universitas Palangka Raya
NCT05019326Phase 3Aug 30, 2021Government of Thailand, Mahidol University
NCT04847518Phase 2/Phase 3 (Phase 3)May 26, 2021Phytomed AB, Swedish Herbal Institute AB, Tbilisi State Medical University
NCT04955327Phase 3Mar 20, 2021Vedic Lifesciences Pvt. Ltd.
NCT04833946N/AMar 13, 2021Vedic Lifesciences Pvt. Ltd.
NCT04161404Phase 1Aug 21, 2019Government of Malaysia, University of Malaya
NCT03597971Phase 1Mar 20, 2018Hutchison MediPharma, Nestle, Nutrition Science Partners Limited
NCT04196075Phase 3Mar 1, 2018Chinese University of Hong Kong
NCT03262792N/ADec 13, 2017Vedic Lifesciences Pvt. Ltd.
NCT03190044N/AJun 6, 2017University of Roma La Sapienza
NCT03134443Phase 4Dec 1, 2016Nanchang University, Qingfeng Pharmaceutical Group
NCT03132610Phase 4Dec 1, 2016Nanchang University, Qingfeng Pharmaceutical Group
NCT03132623Phase 4Dec 1, 2016First Hospital of Shijiazhuang City, Gannan Medical University, Jiujiang First People's Hospital, Nanchang University, Qingfeng Pharmaceutical Group
NCT02913118Phase 4Jul 1, 2016Capital Medical University, China Medical University, First Hospital of QinHuangDao, Hebei University, Nanchang University, Peking University, People's Liberation Army of China, Qingdao Municipal Hospital, Qingfeng Pharmaceutical Group, Shanxi Medical University, Sichuan University, The Central Hospital of ZiBo City, Tianjin Medical University, Wenzhou Medical University
NCT02273635Phase 1/Phase 2 (Phase 2)Sep 1, 2014Innobioscience SpA, Pontificia Universidad Catolica de Chile, Universidad Austral de Chile, University of Chile
NCT01993472Phase 2Nov 1, 2013Nanjing Medical University
NCT01882764Phase 3Jun 1, 2013Hutchison MediPharma, Nutrition Science Partners Limited
NCT01805791Phase 3Mar 1, 2013Hutchison MediPharma
NCT02280876Phase 1/Phase 2 (Phase 2)Jan 1, 2012Universidad Austral de Chile, University of Chile
NCT00659802Phase 2Mar 1, 2008Hutchison MediPharma
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (36)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hutchison MediPharmaFor profit5432006
Nanchang UniversityAcademic/Hospital4012016
Qingfeng Pharmaceutical GroupFor profit4412016
Vedic Lifesciences Pvt. Ltd.For profit3322017
Nutrition Science Partners LimitedFor profit2122013
Universidad Austral de ChileAcademic/Hospital2112012
University of ChileAcademic/Hospital2012012
Capital Medical UniversityAcademic/Hospital1012016
China Medical UniversityAcademic/Hospital1012016
Chinese University of Hong KongAcademic/Hospital1112018
First Hospital of QinHuangDaoAcademic/Hospital1012016
First Hospital of Shijiazhuang CityAcademic/Hospital1012016
Gannan Medical UniversityAcademic/Hospital1012016
Government of MalaysiaGovernment1012019
Government of ThailandGovernment1012021
Hebei UniversityAcademic/Hospital1012016
Innobioscience SpAFor profit1112014
Jiujiang First People's HospitalAcademic/Hospital1012016
Mahidol UniversityAcademic/Hospital1112021
Nanjing Medical UniversityAcademic/Hospital1112013
36 organizations
Page 1 / 2